http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009521988-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 |
| filingDate | 2006-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009521988-A |
| titleOfInvention | Internal medical devices containing peroxide conversion catalyst |
| abstract | The present invention is directed to an implantable and insertable medical device (also referred to herein as an internal medical device) containing one or more peroxide conversion catalysts. According to an aspect of the invention, an internal medical device is provided that includes (a) a substrate and (b) a peptide-containing peroxide conversion catalyst disposed on at least a portion of the substrate. In another aspect of the invention, an internal medical device containing a catalyst binding entity is provided. When the device is implanted or inserted into a patient, the catalyst binding entity is used to bind the endogenous peroxide conversion catalyst. In another aspect of the invention, an internal medical device is provided that includes a biodegradable region and then contains a peroxide conversion catalyst. These devices release this catalyst in conjunction with the degradation of the biodegradable region. In yet another aspect of the invention, an internal medical device is provided that includes a substrate, a multilayer region disposed on at least a portion of the substrate, and a peroxide conversion catalyst disposed in the multilayer region. The multi-layer region includes a plurality of charged layers that are sequentially charged alternately, and the charged layer further includes a plurality of polyelectrolyte-containing layers. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015181984-A |
| priorityDate | 2005-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 357.